MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories
Jump to:  View All • a b c d e f g h i j k l m n [o] p q r s t u v w x y z
  • Objective Monitoring of Axial symptoms in Parkinson’s Disease (OMNIA-PARK): the Study Protocol.

    S. Gallo, M. Patera, G. Imbalzano, A. Zampogna, M. Ghislieri, U. Mosca, G. Amprimo, L. Borzì, S. Cerfoglio, MA. Gazzanti Pugliese, GL. Cerone, A. Botter, V. Cimolin, C. Claudia, L. Lopiano, F. Irrera, G. Olmo, A. Suppa, CA. Artusi (Pozzilli

  • Observations and Strategies for Improving Recruitment and Retention of Underrepresented Populations in Movement Disorders Clinical Research Trials Conducted in a Tertiary Research Site

    I. Saraf, P. Agarwal, L. Patron (Kirkland, USA)

  • Oculomotor Abnormalities in Spinocerebellar Ataxia Type-12: A Functional Neuroimaging Study

    P. Pankaj, A. Srivastava, S. Kumaran, A. Garg, R. Agarwal, M. Kumar, A. Sonakar, A. Nehra (New Delhi, India)

  • Oculomotor Differences in PARK2 PD: a Study of Structured and Unstructured Eye Movements in an Irish Genetic Cohort

    A. Gallagher, C. O'Keeffe, J. Inocentes, M. Bradley, E. Donlon, B. Coe, B. White, R. Walsh, T. Lynch, R. Reilly, D. Munoz, C. Fearon (Dublin, Ireland)

  • Oculopalatal Myoclonus Secondary to Brainstem Hemorrhage: A Case Report

    S. Fu, U. Agarwal, T. Abu-Zahra, Z. Farzal (Detroit, USA)

  • Olfactory-Trigeminal Interactions in Parkinson’s Disease Compared to Other Olfactory Disorders

    S. Brosse, O. Fortier-Lebel, E. Hudon, K. Lapointe, C. Tremblay, J. Frasnelli (Trois-Rivières, Canada)

  • Oligodendrocyte-specific mRNA therapy with lipid nanoparticles

    M. Sawamura, K. Tachikawa, R. Hikawa, H. Yamakado, R. Takahashi, S. Matsuzawa (San Diego, USA)

  • Olivopontocerebellar atrophy and Hot Cross Bun sign in vertical transmitted HIV disease with non emotional pathological crying ; Case report and review literature

    W. Rattanachaisit (Chiang rai, Thailand)

  • Online Learning Preferences of Healthcare Providers Caring for People with Parkinson’s Disease

    A. Smiley, I. Blackwood, L. Hoffman, R. Miller, K. Fitzgerald, C. Gadala-Maria, E. Pollard, A. Paul (Miami, USA)

  • Opicapone for OFF Motor Fluctuations in Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Trials

    A. Fornari Caprara, J. Pitton Rissardo (Camden, USA)

  • Opicapone improves end-of-dose neuropsychiatric fluctuations in patients with Parkinson’s disease

    R. de Fiores, I. Martino, A. Quattrone, B. Vescio, G. Arabia, A. Gambardella, M. Morelli (Catanzaro, Italy)

  • Opicapone in Parkinson’s Patients with Probable REM Sleep Behavior Disorder: Insights from the OASIS Trial

    J. Ferreira, M. Gago, R. Costa, M. Fonseca, H. Brigas, D. Magalhães, J. Holenz, C. Trenkwalder (Lisbon, Portugal)

  • Opsoclonus-Myoclonus Ataxia plus Demyelinating Neuropathy Syndrome in an uncommon type of Prostate Cancer, a Case Report

    V. Parra Payano, N. Ahmed, M. Situ Kcomt (Omaha, USA)

  • Optimization of Adaptive Deep Brain Stimulation Settings in Patients with Parkinson’s Disease

    K. Kimura, H. Kishida, K. Abe, N. Ueda, F. Tanaka (Yokohama, Japan)

  • Optimizing Bereitschaftspotential Detection Using Signal Processing Techniques

    B. Hale, R. Kandasamy, C. Cordivari (London, United Kingdom)

  • Optimizing deep brain stimulation programming settings for patients with stimulation-induced dyskinesias in Parkinson’s disease

    S. Kaul, J. Deng, D. Fletcher, L. Colantonio, A. Memon, MC. Moreno-Escobar, A. Murray, G. Adams, J. Frey (Morgantown, USA)

  • Optimizing Electrode Placement in STN-DBS for Parkinson’s Disease: The Added Value of Intraoperative Neurophysiological Monitoring

    M. de Rosa, A. Gozzi, S. Sensi, M. Sensi (Chieti, Italy)

  • Organoid-Based AI Clinical Trial Platform for Phase 0 Studies in Parkinson’s Disease

    M. Choi, D. Kim (Daejoen, Republic of Korea)

  • Orthostatic Hypotension and Acute Cognitive Dysfunction in Parkinson’s Disease: Insights from fNIRS

    K. Longardner, P. Reddy, M. Skipworth, D. Salmon, K. Izzetoglu, I. Litvan (La Jolla, USA)

  • Outcome of Subthalamic nucleus deep brain stimulation: comparison between clinical-based and LFP-based programming

    MS. Chen, YC. Chen, PL. Chen, PH. Tu, MC. Yeap, CC. Chen (Taoyuan, Taiwan)

  • Outcomes of Algorithm Guided DBS Programming: A case series

    M. Ferris, J. Kim, B. Reid, V. Buch (Palo Alto, USA)

  • Outcomes of Focused Ultrasound Referrals at a Movement Disorders Center

    B. Beehler, M. Kelley, L. Bristol, D. Kramer, S. Ojemann, D. Kern (Aurora, USA)

  • Outcomes of invasive stereotactic thalamotomy using dentatorubrothalamic tractography targeting for patients with drug refractory tremor

    V. Bayarchyk, A. Buniak, A. Mikitchuk (Minsk, Belarus)

  • Oxidative stress in Progressive Supranuclear Palsy

    P. Alster, D. Otto-ślusarczyk, M. Struga, N. Madetko-Alster (Warsaw, Poland)

Jump to:  View All • a b c d e f g h i j k l m n [o] p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley